Introduction: Exercise-induced desaturation is a common finding in patients with moderate and severe COPD. It is an important marker in the course of disease that has a prognostic value for mortality risk. Aim: To monitor over time COPD patients with and without desaturation during 6-minute walking test (6MWT) and to assess the stability of that phenomenon. Materials and methods: A 6MWT was administered to 70 patients with COPD which ranged in severity from stage 2A to stage 4D (GOLD 2011); the patients had a mean age of 64.5±10.1, mean pack-years -38.8±21, FEV 1% = 46.4%±15.7%, FVC% = 73.7%±1.3%, МRС = 2.31±0.84, САТ = 20.8±6.6. Oxygen saturation was monitored during the test; indications for desaturation were a decrease of SpO2 by ≥4% and a fall in SpO2 to ≤88% for at least 3 min. The patients were followed-up for mean 40.9±22.3 months and tests were repeated. Results: Patients were divided into two groups based on the decrease in SpO 2: Group A included patients with desaturation (n=35) and Group B -patients with no desaturation (n=35). In 66 of the patients the desaturation profile was stable over time. Only two patients, who did not desaturated at baseline, experienced desaturation in the follow-up 6MWT and another two patients, who desaturated at baseline, did not have it later in the follow-up. Conclusion: Desaturation is a phenomenon that is persistent over time. Based on the results, it could be concluded that exercise-induced desaturation is a major marker of a particular COPD phenotype.
INTRODUCTION
There is a significant heterogeneity in clinical features and course of disease among COPD patients. It is well known that apart from pulmonary symptoms, there are plenty of extrapulmonary ones that in some cases may lead to complications permanently worsening the condition and the prognosis. A good understanding of the complexity of that disease on a clinical, cellular and molecular levels and the complicated interaction of different pathophysiological mechanisms combined with a particular genetic predisposition in different patients explains the different course of disease and prognosis in people with the same diagnosis of COPD. At first diagnoses assessing the severity and monitoring the treatment effect were all made on the basis of airflow limitation (FEV 1 ), but as data amassed it became clear that considering only this parameter is not enough for the full assessment of the patient. The inclusion of exacerbations, symptoms and comorbidity evaluation in the latest revisions of GOLD is a step in the right direction and gives us additional tools to establish an individual therapeutic plan for patients from different groups. 1, 2 The so called "clinical phenotyping" is at the basis of the identification of different subgroups of COPD patients which differ from each other in exacerbations, symptoms severity, course of disease, response to treatment, and mortality.
Testing the physical capacity of COPD patients has a great value in evaluating the severity of the disease in individual patients, the prognosis and in determining the therapeutic approach in the different groups (phenotypes). 3 Monitoring the saturation via pulse oximetry during exercise tests (6 Minute Walk Test, 6MWT) and cardio-pulmonary exercise test, CPET) allows us to detect easily and reliably the patients who desaturate while exercising. [4] [5] [6] The phenomenon of desaturation is common in the advanced stages of COPD and has complex pathogenesis related to airflow limitation, ventilation/perfusion mismatch, shunting of venous blood in the arterial circulation, decreased diffusion capacity, systemic inflammation and oxidative stress, leading to disbalance between oxygen supply and consumption.
Identifying and monitoring the "desaturators" in the COPD population is part of searching the combinations of disease signs which describe the difference between COPD individuals and which relate them to important clinical results for the single patient. 7, 8 
AIM
To monitor continuously COPD patients with and without desaturation during 6MWT and to find out if this phenomenon is stable over time.
MATERIALS AND METHODS
The study was carried out in the Departments of Pulmonology, Cardiology and Pathophysiology in the Medical University of Plovdiv, Bulgaria, between 2009 and 2017.
Seventy male patients with COPD in different stages were included in the study. According to the GOLD 2011 criteria, they were as follows: 2A -1 patient; 2B -20 patients; 3D -33 patients; 4D -16 patients ( Table 1) .
Study incluSion criteria
Patients in COPD stages from 2A to 4D (GOLD) in a stable condition -not in exacerbation of COPD or any of the concomitant diseases.
excluSion criteria -Left heart failure [ejection fraction (ЕF) ≤ 50%, brain natriuretic peptide (BNP) ≥ 150 pg/mL], uncontrolled rhythm disorders, unstable coronary artery disease (CAD), recent myocardial infarction (MI) and post-pulmonary thromboembolism (PTE) conditions. In all patients a baseline echocardiography and ECG were performed to exclude left ventricular dysfunction of myocardial or valvular type.
-Bronchial asthma -Pulmonary carcinoma -Musculoskeletal or other diseases which make performing the 6MWT and CPET impossible -Active pulmonary tuberculosis Complete medical history regarding current, previous and concomitant diseases, tobacco smoking and pack/years, number of exacerbations in the last year, was obtained from each patient. We subjected the patients to the following tests: spirometry with a bronchodilator test (BDT); bodyplethysmography and measurement of the diffusion capacity (Master Screen Diffusion/Body, E. Jaeger, Germany); bloodgas analysis of arterialized capillary blood (ABL 830 FLEX, Radiometer, Denmark); 6 minute walk test (6MWT).
-6MWT was performed in a closed 35-meterlong corridor; the tested subjects were asked to walk for 6 minutes and cover as much distance as possible. The patients were instructed to walk from one end of the corridor to the other as fast as they can for 6 minutes. They were allowed to stop for a rest. During walking the subjects were encouraged with standard phrases. 4 The covered distance was measured in meters. At baseline and at the end of the test, dyspnea was assessed by the modified Borg scale (1-10). Each patient performed the test minimum 2 times in 2 days. In the follow-up visit spirometry, 6MWT and filling-up the quality of life questionnaires [modified Medical Research Council (mMRC), COPD-assessment test (CAT)] were performed in a single day.
-Oxygen saturation was monitored during the 6MWT by a pulse oximeter PalmSat 2500+ (Nonin Medical, Plymouth, MN, USA) and a decrease of SpO 2 by ≥ 4% and oxygen saturation ≤ 88% were considered a desaturation event.
-Every patient underwent echocardiography (HP, Sonos 2500 System, USA). Left ventricular ejection fraction was evaluated via Simpson's method. The mean pressure in the pulmonary artery (mPAP) was calculated automatically by the system's software.
-BNP is a diagnostic marker of heart failure (HF). Biological material: venous blood with EDTA as an anticoagulant. The separated plasma was contained in -70°C until its processing. The device used was Sirio S microplate reader, SEAC, Italy and the method: competitive inhibition enzymatic immunoassay.
-The standardized test mMRC, Saint George Respiratory Questionnaire (SGRQ) and CAT were used to evaluate quality of life, dyspnea perception and the related with it limitation of physical activity. [9] [10] [11] [12] [13] [14] -Monitoring of the patients was performed for 40.9±22.3 (mean±SD) months with repetition of the 6MWT, mMRC and CAT.
The study design was reported at a local Ethics Committee at the Medical University of Plovdiv and all its stages and components were approved. All patients who matched the inclusion/exclusion criteria were thoroughly informed about the study and signed informed consents prior to taking any actions related to the study.
StatiStical analySiS
Data were analysed using SPSS v. 22.0 for Windows (SPSS, Chicago, USA). The results were presented as mean value ± standard deviation (mean±SD), except where otherwise stated. Sometimes we reported the minimal and maximal values in order to give an idea about the range. Kolmogorov-Smirnov test was used to check for normal distribution. Comparing two means was done with Student's t-test, respectively for independent variables -independent samples T-test and for related variables -paired samples T-test. When analyzing the dependencies between normally distributed quantitative variables, we used Pearson's coefficient of correlation. To assess the reproducibility of the 6MWT in regards of manifesting desaturation on exertion the coefficient of agreement kappa was used. It is used to compare two separate measurements, especially when a gold standard is missing. The coefficient of agreement kappa is a measurement of test reproducibility; κ > 0.7 is considered a good test, while a malfunctioning test is with κ < 0.3. To establish determinants of the percentage desaturation we used stepwise regression analysis. The significance level for the null hypothesis was p < 0.05.
RESULTS
Of 70 tested patients, 35 (50%) desaturated during the 6MWT. In the follow-up for 40.9±22.3 months on average the desaturation profile remained unchanged in 66 (94%) of them (Fig. 1) .
To assess the reproducibility of the 6MWT in terms of inducing desaturation on exertion, we used the statistical method Kappa. As we performed two series of tests in a different time interval, we created a two-dimensional array to represent all data variations. After processing, the result for κ = 0.886 which demonstrates the high degree of reproducibility and gives reason to consider desaturation as a phenomenon describing initial pathophysiological mechanisms, forming the disease and it is stable over time in that patient population.
On the basis of the decrease in SpO 2 during the test, the patients were divided into two groups - with a desaturation (A) and with no desaturation (B) ( Table 2 ).
The two groups differ significantly in terms of FEV1%; FVC%, IC%; diffusion capacity, corrected for alveolar volume (KCO%); PaO 2 ; PaCO 2 ; baseline SpO 2 , mMRC, mPAP and 6 MWT (p < 0.05), but not in terms of САТ, SGRQ, Charlson Comorbidity Index (CCI), EF% pred., and number of exacerbations in the last year ( Table 2) .
The percentage desaturation in the whole group ΔSpO 2 6.3±5.0% correlates with the basic spirometric and blood-gas parameters The stepwise regression analysis was performed including parameters from spirometry, blood-gas analysis, diffusion, scales for dyspnea and symptoms assessment, 6MWT, basal SpO 2 , mean pressure in the pulmonary artery (mPAP), comorbidity, smoking in pack/years, BMI, age (years) and the number of We found 35 patients (50%) in the present study that desaturated during the 6MWT and the desaturation profile remained unchanged over time in 66 of all the tested subjects (94%). Jenkins S et al. 23 reported a study of a large group of people with chronic pulmonary diseases (741 patients) of which 572 with COPD and 47% (n=345) desaturated during 6MWT. Van Gestel et al. 24 also found a considerable prevalence of desaturation among COPD patients using the same test (61.7% out of the total 154 included in their study). Other authors have reported a frequency of desaturation among COPD patients between 29% and 55% and despite the different criteria and different studied populations it is safe to assume that this is a quite common finding in the late stages of COPD. 21, 28, 30 To date there has been no widely accepted definition of desaturation and unified criteria for its detection in different types of physical exercise. There are different criteria to evaluate the absolute and relative decreases of PaO 2 and SpO 2 for detection of hypoxemia in physical exercise. 15 The borderline values for SpO 2 are usually ≤88-90%, as the extent of decrease from baseline ranges from 2% to 5%. The duration in which the SpO 2 values are below the appointed threshold is also rarely defined, varying in the different sources between 0.5 and 5 minutes. 15 The exercise tests used to objectivize presence or absence of desaturation are also a wide variety: from everyday physical activity, 6MWT, shuttle tests and stair climb tests, to CPET with incremental or constant load performed on a treadmill or a ergometer. 15 Those substantial variations lead to considerable confusion and misinterpretation of study results. After taking into account a lot of considerations and previously published experience we defined our own criteria for desaturation. We aimed to prove unequivocally the drop in SpO 2 via recorded continuous pulse oximetry for the time of the whole 6MWT, as the requirement for the value being ≤88% for a minimum of 3 minutes eliminates the possibility for technical mistakes. In all the tested subjects we performed at baseline echocardiography and BNP measurement to exclude the presence of heart failure which would have altered the results and would have led to misinterpretation. In 66 of the patients, we observed no changes in the desaturation profile. Two of the patients with baseline desaturation did not experience such in the subsequent tests and in another two it appeared for the first time on the later tests. We presume that desaturation is a phenomenon determined by the interaction between the pathophysiological mechanisms forming the disease, it persists over time in the majority of COPD patients where it leads to faster progression and more severe disease course. 34 Desaturation on exertion is probably a characteristic feature of a specific COPD "phenotype" rather than an event, occurring in the normal disease course.
Monitoring saturation continuously for the whole time of the 6MWT makes it possible to detect desaturation. This is a safe and secure test which does not require expensive technical equipment and highly trained personnel, yet it is comparable to the "gold standard" CPET. 3, 16 The 6MWT is well studied in terms of reproducibility of the distance covered and sensitivity for therapeutic interventions 4,17 , but not so well in terms of reproducibility of desaturation.
Poulain et al. compare 6MWT and CPET on an ergometer in 80 patients with COPD and concludes that the 6MWT is more sensitive for desaturation detection during exercise. The used criterion was a decrease in the SpO 2 by ≥4% for a minimum of the least 3 minutes of the test. The results were reproducible regardless of the protocol and this allows us to use them when prescribing O 2 therapy at home. 18 Hernandes et al. check the reproducibility of 6MWT in a retrospective observational study including 1544 COPD patients who performed two tests on two consecutive days. Criteria for desaturation were either a difference between baseline and final SpO 2 ≥ 4% and/or final SpO 2 < 88% and desaturation reproducibility also was assessed. The average change in oxygen saturation during the first and second 6MWT was -5.7% (95% CI -15-0%) and -5.5% (95% CI -16-0%), respectively. The authors conclude that the change in SpO 2 during 6MWT is reproducible (ICC -0.81, р < 0.001). Besides, the sensitivity and specificity for predicting desaturation during the second 6MWT based on the results from the first were 80% and 77%, respectively. 19 Contrary to those results, Chatterjee et al. 20 studied 88 COPD patients and found only moderate reproducibility κ = 0.62 in 3 6MWT performed in an average period of 21 days, but the desaturation criteria in their study included minimal duration of only 5 seconds which significantly differs from our criterion of minimum 3 minutes.
Stolz et al. studied 574 COPD patients and a follow-up of 2 years, as a control 6MWT was performed each year. Criterion for desaturation was a decrease of SpO 2 to <88% with no specified duration. On the basis of their data, the authors calculate that the probability after one year for those who were not desaturators at baseline to experience desaturation is 21.6%, for the desaturators there was 37.3% probability to remain such and 48.5% probability to not suffer from desaturation on a subsequent test after one year. The authors conclude that this phenomenon has a low reproducibility and is rather intermittent in COPD patients but they clearly declare that their results should not be extrapolated to other definitions of desaturation. 21 Garcia-Talavera et al. studied 83 COPD patients for 5 years --all of them desaturating during 6MWT as at baseline they conducted two 6MWTs at a 30-minute interval and the patients were divided into early desaturators -in the first minute and late desaturators -after the first minute. Every 6 months they performed another 6MWT with constant pulse oximetry. The authors conclude that over a 5-year period, 65% of the so-called early desaturators develop severe hypoxemia and require long-term O 2 therapy, while such development was seen in only 11% of the late desaturators. The authors do not report any patients who have changed their desaturation profile in the course of the study although such assessment was not among the objectives of the study. 22 We found that the desaturators with COPD differ significantly from the non-desaturators dur-ing 6MWT in their spirometric and blood-gas parameters (FEV 1 %, FVC%, IC%, PaO 2 , PaCO 2 ), baseline SpO 2 and minimal SpO 2 , diffusion parameters (KCO%), the distance covered during the 6MWT and mMRC, but not in the symptom assessment scales (SGRQ and CAT), comorbidity and the number of exacerbations in the last year.
Hussein et al. 27 include 55 patients in a study where they were divided into desaturators and nondesaturators on the basis of SpO 2 during CPET and found out that in desaturators FEV 1 %, DLCO% and baseline SpO 2 were significantly lower, while PaCO 2 , mPAP and mMRC scores were significantly higher. Dogra et al. 28 test 60 COPD patients and report a high risk (55%) of desaturation during 6MWT. When dividing the subjects based on presence or absence of desaturation they found out a significant inverse correlation between desaturation and FEV 1 %, SpO 2 at rest, and the distance covered in 6MWT. With our patients we got similar results and correlations.
The decrease in oxygen saturation during exercise is not a rare event in the late stages of COPD. 23, 24 It is related to a more severe and unfavourable disease course and significantly increases mortality risk. 25, 26 In regards of those findings some researchers are trying to figure out which of the parameters in examined COPD patients could alone or in combination be useful for a good prediction.
In the subjects we tested, there is a moderate correlation with FEV 1 %, but there is also a correlation with the diffusion and blood-gas parameters (КСО% r = -0.45; p = 0.001; PaO 2 r = -0.55; p = 0.001), basal SpO 2 (r = -0.55; p = 0.001) and 6MWT (m) (r = -0.33; p = 0.005).
Using a stepwise regression analysis we established that only PaO 2 , KCO and baseline SpO 2 are significant determinants of the percent desaturation ΔSpO 2 .
Van Gestel et al. 24 found out that values of FEV 1 % < 50% could predict to a considerable degree the occurrence of desaturation during 6MWT. Crisafulli et al. suggest a score system for risk assessment for the same phenomenon, based on a statistical model, using correlation and multifactorial regression analyses. The authors studied two cohorts of patients, 435 and 238 respectively and reported that out of the tested functional variables, the ones able to credibly predict desaturation during 6MWT were: SаO 2 (r = 0.65), PaO 2 (r = 0.50) and FEV 1 % (r = 0.41). For each parameter a cut-off value was calculated corresponding to a certain score as the end results ranges from 0 to 6. By classifying the patients as being at low risk (0-1 points), high risk (2-3 points) and very high risk (4-6 points) they establish the strong predictive value of the three parameters. 29 Andrianopoulos et al. 30 studied 402 COPD patients who had normal PaO 2 and PaCO 2 values at rest. In 39% of them there was a desaturation during 6MWT with a nadir < 88%. One of the aims, set by the authors was to identify which ones of the routinely used parameters for COPD patients could predict the occurrence of the phenomenon during physical exercise. Using a multifactorial regression model they found out that in 95% of the patients, values of FEV 1 % < 45%, DLCO < 50%, PaO 2 at rest < 10 kPa and baseline saturation < 95% predict the occurrence of desaturation -the same parameters with which we established correlation. 30 Based on our results we suggest that the desaturation during 6MWT, when strictly defined, is a stable and reproducible phenomenon in a considerable part of the COPD patients. The desaturation on exertion is a result of the interaction between the pathophysiological mechanisms forming the disease and it predetermines faster progression and more severe disease course in that subpopulation of patients. 34 The combination of functional and blood-gas parameters under certain conditions could be useful in predicting desaturation occurrence, but the best way to prove it is to perform a standardized test with physical exercise with a constant monitoring of pulse oximetry. The desaturation in exertion is probably a core characteristic of a "phenotype" of COPD rather than an event, occurring in the normal evolution of the disease.
The phenomenon of desaturation during 6MWT is stable and reproducible over time. Patients with desaturation present with lower spirometric and blood-gas parameters, symptom scores and more limited physical capacity. In that subpopulation of COPD patients the disease course is less favourable and prognosis is worse. Based on that data we consider the desaturation on exertion to be a main marker of a separate COPD phenotype.
